DL-017
Изглед
Nazivi | |
---|---|
Preferisani IUPAC naziv
3-[[4-(2-metoksifenil)piperazin-1-il]metil]-5-metilsulfanil-2,3-dihidroimidazo[1,2-c]hinazolin | |
Drugi nazivi
SCHEMBL5674428
CHEMBL1744044 L001577 | |
Identifikacija | |
3D model (Jmol)
|
|
| |
Svojstva | |
C23H27N5OS | |
Molarna masa | 421,56 g·mol−1 |
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa). | |
Reference infokutije | |
DL-017 je antagonist alfa adrenergičkog receptora.[3]
Reference
[уреди | уреди извор]- ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.
- ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
- ^ L M Tsai; S N Yang; S F Lee; Y A Ding; J W Chern; J M Yang (2001). „Antihypertensive action and blockade of alpha1-adrenoceptors by DL-017, a quinazoline derivative”. J Cardiovasc Pharmacol. 38 (6): 893—9. doi:10.1097/00005344-200112000-00011.